Intracellular antigens—from viruses, tumors, bacteria and other sources—pose a challenge to the immune response and to vaccine development. How do such antigens enter antigen-presenting cells? Three new studies examine this process, implicating whole proteins instead of small peptides as key intermediaries.
- Keith S Bahjat
- Stephen P Schoenberger
